Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
Treatment of Metastatic Medull...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply
書目詳細資料
Main Authors:
Jr, W
,
Robinson, BG
,
Gagel, R
,
Dralle, H
,
Fagin, J
,
Santoro, M
,
Baudin, E
,
Elisei, R
,
Jarzab, B
,
Vasselli, JR
,
Read, J
,
Langmuir, P
,
Ryan, A
,
Schlumberger, M
格式:
Journal article
出版:
2012
持有資料
實物特徵
相似書籍
職員瀏覽
相似書籍
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
由: Wells, SA, et al.
出版: (2012)
Reply to J.-F. Chatal et al.
由: Wells Jr, SA, et al.
出版: (2012)
Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
由: Nils Degrauwe, et al.
出版: (2012-06-01)
Calcitonin receptor expression in medullary thyroid carcinoma
由: Virginia Cappagli, et al.
出版: (2017-09-01)
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
由: Ecem Bostan, et al.
出版: (2022-09-01)